These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34891563)

  • 41. Human-in-the-Loop Insulin Dosing.
    Bequette BW
    J Diabetes Sci Technol; 2021 May; 15(3):699-704. PubMed ID: 31801361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advanced hybrid artificial pancreas system improves on unannounced meal response - In silico comparison to currently available system.
    Garcia-Tirado J; Lv D; Corbett JP; Colmegna P; Breton MD
    Comput Methods Programs Biomed; 2021 Nov; 211():106401. PubMed ID: 34560603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Automated Insulin Delivery Systems: Today, Tomorrow and User Requirements.
    Giménez M; Conget I; Oliver N
    J Diabetes Sci Technol; 2021 Nov; 15(6):1252-1257. PubMed ID: 34291672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The artificial pancreas.
    Boughton CK; Hovorka R
    Curr Opin Organ Transplant; 2020 Aug; 25(4):336-342. PubMed ID: 32618719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Based on Total Daily Insulin in Adolescents with Type 1 Diabetes.
    Schoelwer MJ; Robic JL; Gautier T; Fabris C; Carr K; Clancy-Oliveri M; Brown SA; Anderson SM; DeBoer MD; Cherñavvsky DR; Breton MD
    Diabetes Technol Ther; 2020 Aug; 22(8):594-601. PubMed ID: 32119790
    [No Abstract]   [Full Text] [Related]  

  • 46. Do-It-Yourself (DIY) Systems in Diabetes: A Family and Provider Perspective.
    Duke MD; Fredlock AA
    J Diabetes Sci Technol; 2020 Sep; 14(5):917-921. PubMed ID: 32131623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The shifting paradigm of a "cure" for type 1 diabetes: is technology replacing immune-based therapies?
    Pettus J; Von Herrath M
    Acta Diabetol; 2018 Feb; 55(2):117-120. PubMed ID: 29188386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evolution of Diabetes Technology.
    Dovc K; Battelino T
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):1-18. PubMed ID: 31980111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes.
    Morrison AE; Chong K; Senior PA; Lam A
    PLoS One; 2022; 17(8):e0271096. PubMed ID: 35951597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. "Do It Yourself" (DIY)-Automated Insulin Delivery (AID) Systems: Current Status From a German Point of View.
    Heinemann L; Lange K
    J Diabetes Sci Technol; 2020 Nov; 14(6):1028-1034. PubMed ID: 31875681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medicine. A pancreas in a box.
    Clery D
    Science; 2014 Jan; 343(6167):133-5. PubMed ID: 24408414
    [No Abstract]   [Full Text] [Related]  

  • 52. The automated pancreas: A review of technologies and clinical practice.
    Biester T; Tauschmann M; Chobot A; Kordonouri O; Danne T; Kapellen T; Dovc K
    Diabetes Obes Metab; 2022 Jan; 24 Suppl 1():43-57. PubMed ID: 34658126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of Glucagon in Automated Insulin Delivery.
    Wilson LM; Jacobs PG; Castle JR
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):179-202. PubMed ID: 31980117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Artificial pancreas: where are we in 2020 ?].
    Radermecker RP
    Rev Med Suisse; 2020 Aug; 16(703):1494-1497. PubMed ID: 32852170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Closing the loop: combining insulin pumps and glucose sensors in children with type 1 diabetes mellitus.
    Shalitin S; Phillip M
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():45-9. PubMed ID: 16774618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Impact of Technology on Current Diabetes Management.
    Garvey K; Wolfsdorf JI
    Pediatr Clin North Am; 2015 Aug; 62(4):873-88. PubMed ID: 26210622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The artificial pancreas: how close are we to closing the loop?
    Clarke WL; Kovatchev B
    Pediatr Endocrinol Rev; 2007 Jun; 4(4):314-6. PubMed ID: 17643078
    [No Abstract]   [Full Text] [Related]  

  • 58. Assessing patient-reported outcomes for automated insulin delivery systems: the psychometric properties of the INSPIRE measures.
    Weissberg-Benchell J; Shapiro JB; Hood K; Laffel LM; Naranjo D; Miller K; Barnard K
    Diabet Med; 2019 May; 36(5):644-652. PubMed ID: 30761592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The artificial pancreas: current status and future prospects in the management of diabetes.
    Peyser T; Dassau E; Breton M; Skyler JS
    Ann N Y Acad Sci; 2014 Apr; 1311():102-23. PubMed ID: 24725149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?
    Boughton CK; Hovorka R
    Diabet Med; 2019 Mar; 36(3):279-286. PubMed ID: 30183096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.